UB Paderborn / Katalog / Suche / in CDI

A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

The Pediatric infectious disease journal, 2020-08, Vol.39 (8), p.763

2020

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults

Human vaccines & immunotherapeutics, 2019-03, Vol.15 (3), p.530-539

2019

Link zum Volltext

Verfügbarkeit prüfen

Optimization and validation of a microcolony multiplexed opsonophagocytic killing assay for 15 pneumococcal serotypes

Bioanalysis, 2020-07, Vol.12 (14), p.1003-1020

2020

Link zum Volltext

Verfügbarkeit prüfen

Enhanced antipneumococcal antibody electrochemiluminescence assay: validation and bridging to the WHO reference ELISA

Bioanalysis, 2020-10, Vol.12 (19), p.1363-1375

2020

Link zum Volltext

Verfügbarkeit prüfen

Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types

mSphere, 2023-04, Vol.8 (2), p.e0096221-e0096221

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU)

Human vaccines & immunotherapeutics, 2022-12, Vol.18 (1), p.1-14

2022

Link zum Volltext

Verfügbarkeit prüfen

The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C

Human vaccines & immunotherapeutics, 2023-08, Vol.19 (2), p.2235238-2235238

2023

Link zum Volltext

Verfügbarkeit prüfen

Three-Year Follow-up of 2-Dose Versus 3-Dose HPV Vaccine

Pediatrics (Evanston), 2021-01, Vol.147 (1), p.1

2021

Link zum Volltext

Verfügbarkeit prüfen

Development and Validation of a Sensitive and Robust Multiplex Antigen Capture Assay to Quantify Streptococcus pneumoniae Serotype-Specific Capsular Polysaccharides in Urine

mSphere, 2022-08, Vol.7 (4), p.e0011422-e0011422

2022

Link zum Volltext

Verfügbarkeit prüfen

Raising the Bar: Using Simulation to Advance Staff Competency Regarding the Patient Experience

Journal for nurses in professional development, 2020-09, Vol.36 (5), p.294

2020

Link zum Volltext

Verfügbarkeit prüfen

P06 The 15-valent pneumococcal conjugate vaccine (PCV) V114 induces cross-reactive antibodies against pneumococcal serotype 6C

JAC-antimicrobial resistance, 2023-01, Vol.5 (Supplement_1)

2023

Link zum Volltext

Verfügbarkeit prüfen

2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability & Cut Point Appropriateness

Bioanalysis, 2022-06, Vol.14 (11), p.737-793

2022

Link zum Volltext

Verfügbarkeit prüfen

2023 White Paper on Recent Issues in Bioanalysis: ISR for ADA Assays, the Rise of dPCR vs qPCR, International Reference Standards for Vaccine Assays, Anti-AAV TAb Post-Dose Assessment, NanoString Validation, ELISpot as Gold Standard

Bioanalysis, 2024-04, Vol.16 (7), p.77-119

2024

Link zum Volltext

Verfügbarkeit prüfen

1972. Safety and Immunogenicity of 15-Valent Pneumococcal Conjugate Vaccine (PCV-15) Compared with PCV-13 in Healthy Older Adults Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23)

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S572-S572

2018

Link zum Volltext

Verfügbarkeit prüfen

Live attenuatedListeria monocytogenesexpressing HIV Gag: Immunogenicity in rhesus monkeys

Vaccine, 2007-10, Vol.25 (42), p.7470

2007

Link zum Volltext

Verfügbarkeit prüfen

The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C

Human Vaccines & Immunotherapeutics, 2023, Vol.19 (2)

2023

Link zum Volltext

Verfügbarkeit prüfen

Post-stroke lateropulsion and rehabilitation outcomes: a retrospective analysis

Disability and rehabilitation, 2022-09, Vol.44 (18), p.5162-5170

2022

Link zum Volltext

Verfügbarkeit prüfen

Indicators of mental disorders in UK Biobank—A comparison of approaches

International journal of methods in psychiatric research, 2019-09, Vol.28 (3), p.e1796-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Kinetics of the Cellular and Transcriptomic Response to Eimeria maxima in Relatively Resistant and Susceptible Chicken Lines

Frontiers in immunology, 2021-03, Vol.12, p.653085-653085

2021

Link zum Volltext

Verfügbarkeit prüfen

Cyclization of 4‑Phenoxy-2-coumarins and 2‑Pyrones via a Double C–H Activation

Organic letters, 2016-06, Vol.18 (11), p.2540-2543

2016

Link zum Volltext

Verfügbarkeit prüfen

Current trends in rapid tests for mycotoxins

Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment, 2019-05, Vol.36 (5), p.800-814

2019

Link zum Volltext

Verfügbarkeit prüfen

Accuracy of the Australian National Sub-Acute and Non-Acute Patient Classification in predicting rehabilitation length of stay for stroke survivors who are ≥65 years of age and have lateropulsion

Topics in stroke rehabilitation, 2023-03, Vol.30 (2), p.203-211

2023

Link zum Volltext

Verfügbarkeit prüfen

Increased growth in sunflower correlates with reduced defences and altered gene expression in response to biotic and abiotic stress

Molecular ecology, 2011-11, Vol.20 (22), p.4683-4694

2011

Link zum Volltext

Verfügbarkeit prüfen

Enablers and Barriers to Accessing Healthcare Services for Aboriginal People in New South Wales, Australia

International journal of environmental research and public health, 2021-03, Vol.18 (6), p.3014

2021

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults

Optimization and validation of a microcolony multiplexed opsonophagocytic killing assay for 15 pneumococcal serotypes

Enhanced antipneumococcal antibody electrochemiluminescence assay: validation and bridging to the WHO reference ELISA

Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types

Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU)

The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C

Three-Year Follow-up of 2-Dose Versus 3-Dose HPV Vaccine

Development and Validation of a Sensitive and Robust Multiplex Antigen Capture Assay to Quantify Streptococcus pneumoniae Serotype-Specific Capsular Polysaccharides in Urine

Raising the Bar: Using Simulation to Advance Staff Competency Regarding the Patient Experience

P06 The 15-valent pneumococcal conjugate vaccine (PCV) V114 induces cross-reactive antibodies against pneumococcal serotype 6C

2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability & Cut Point Appropriateness

2023 White Paper on Recent Issues in Bioanalysis: ISR for ADA Assays, the Rise of dPCR vs qPCR, International Reference Standards for Vaccine Assays, Anti-AAV TAb Post-Dose Assessment, NanoString Validation, ELISpot as Gold Standard

1972. Safety and Immunogenicity of 15-Valent Pneumococcal Conjugate Vaccine (PCV-15) Compared with PCV-13 in Healthy Older Adults Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23)

Live attenuatedListeria monocytogenesexpressing HIV Gag: Immunogenicity in rhesus monkeys

The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C

Post-stroke lateropulsion and rehabilitation outcomes: a retrospective analysis

Indicators of mental disorders in UK Biobank—A comparison of approaches

Kinetics of the Cellular and Transcriptomic Response to Eimeria maxima in Relatively Resistant and Susceptible Chicken Lines

Cyclization of 4‑Phenoxy-2-coumarins and 2‑Pyrones via a Double C–H Activation

Current trends in rapid tests for mycotoxins

Accuracy of the Australian National Sub-Acute and Non-Acute Patient Classification in predicting rehabilitation length of stay for stroke survivors who are ≥65 years of age and have lateropulsion

Increased growth in sunflower correlates with reduced defences and altered gene expression in response to biotic and abiotic stress

Enablers and Barriers to Accessing Healthcare Services for Aboriginal People in New South Wales, Australia

The current understanding of precision medicine and personalised medicine in selected research disciplines: study protocol of a systematic concept analysis

Aktive Filter

Suchergebnisse filtern